TY - JOUR
T1 - Hemodynamic alteration by fetal surgery accelerates myocyte proliferation in fetal guinea pig hearts
AU - Saiki, Yoshikatsu
AU - Konig, Andrea
AU - Waddell, Jill
AU - Rebeyka, Ivan M.
N1 - Funding Information:
Supported by the Heart and Stroke Foundation (grant #A2234) and the Priede fund. Presented at the Fifty-eighth Annual Meeting of the Society University Surgeons, Tampa, Fla., Feb. 13-15, 1997. Reprint requests: Ivan M. Rebeyka, MD, Division of Cardiac Surgery, University of Alberta, 382.04 WC Mackenzie Centre, 8446112 St., Edmonton, Alberta, Canada T6G 2B7. Copyright 0 1997 by Mosby-Year Book, Inc. 0039-6060/97/$5.00 + 0 11/6/82435
PY - 1997/8
Y1 - 1997/8
N2 - Background. Fetal heart development occurs by hyperplasia as myocytes lose the capacity to proliferate at birth. This potential for cell division may have application in altering fetal growth patterns in congenital cardiac malformations, but it is not known whether the proliferative activity can be modified by intrauterine surgical manipulation. The purpose of this study was to determine whether hemodynamic alteration by fetal surgery influences myocyte proliferation and myocardial development. Methods. Six pregnant guinea pigs of 50 to 52 days of gestation (term, 65 days) underwent hysterotomy, and the fetal ascending aorta was banded and narrowed by 50% (AoB). Cesarean section was performed near term, and the heart was assessed for myocyte proliferative activity (Ki-67 monoclonal antibody), apoptosis, and morphologic features. Results. The heart to body weight ratio (1.02% ± 0.12% versus 0.42% ± 0.02%, p < 0.01) and left ventricular posterior wall thickness (1.89 ± 0.25mm versus 1.31 ± 0.19 mm, p < 0.01) were significantly higher in the AoB group. The percentage of Ki-67 positive cells was increased in AoB group (29.5% ± 4.4% versus 15.3% ± 1.3% in right ventricle, 35.8% ± 5.1% versus 13.1% ± 1.7% in interventricular septum, and 39.8% ± 3.2% versus 12.0% ± 2.0% in left ventricle (p < 0.01). The apoptotic cell to myocyte ratio was less than 1/1000 in both groups. Conclusions. Fetal hemodynamic alteration by aortic banding accelerates myocardial cellular proliferation without affecting apoptosis, suggesting that in utero cardiac interventions have a greater influence on myocardial development compared with postnatal intervention.
AB - Background. Fetal heart development occurs by hyperplasia as myocytes lose the capacity to proliferate at birth. This potential for cell division may have application in altering fetal growth patterns in congenital cardiac malformations, but it is not known whether the proliferative activity can be modified by intrauterine surgical manipulation. The purpose of this study was to determine whether hemodynamic alteration by fetal surgery influences myocyte proliferation and myocardial development. Methods. Six pregnant guinea pigs of 50 to 52 days of gestation (term, 65 days) underwent hysterotomy, and the fetal ascending aorta was banded and narrowed by 50% (AoB). Cesarean section was performed near term, and the heart was assessed for myocyte proliferative activity (Ki-67 monoclonal antibody), apoptosis, and morphologic features. Results. The heart to body weight ratio (1.02% ± 0.12% versus 0.42% ± 0.02%, p < 0.01) and left ventricular posterior wall thickness (1.89 ± 0.25mm versus 1.31 ± 0.19 mm, p < 0.01) were significantly higher in the AoB group. The percentage of Ki-67 positive cells was increased in AoB group (29.5% ± 4.4% versus 15.3% ± 1.3% in right ventricle, 35.8% ± 5.1% versus 13.1% ± 1.7% in interventricular septum, and 39.8% ± 3.2% versus 12.0% ± 2.0% in left ventricle (p < 0.01). The apoptotic cell to myocyte ratio was less than 1/1000 in both groups. Conclusions. Fetal hemodynamic alteration by aortic banding accelerates myocardial cellular proliferation without affecting apoptosis, suggesting that in utero cardiac interventions have a greater influence on myocardial development compared with postnatal intervention.
UR - http://www.scopus.com/inward/record.url?scp=0030867962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030867962&partnerID=8YFLogxK
U2 - 10.1016/S0039-6060(97)90034-9
DO - 10.1016/S0039-6060(97)90034-9
M3 - Article
C2 - 9288148
AN - SCOPUS:0030867962
SN - 0039-6060
VL - 122
SP - 412
EP - 419
JO - Surgery
JF - Surgery
IS - 2
ER -